Pancreatic Cancer Research

ResearcherKorea Research Institute of Bioscience and BiotechnologyActive in the last 2 years

Sang Seok Koh

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5113798370. Sources: OpenAlex.

Their work

Papers
18 (first author 2, last author 7)
Trials
0
Grants
0
Labs led
2
Collaborators
36
Papers, trials and grants by year

2011: 4 papers · 2012: 1 paper · 2013: 2 papers · 2014: 1 paper · 2015: 3 papers · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: 2 papers · 2023: none · 2024: 1 paper

Papers 18

  1. Pancreatic Adenocarcinoma Up-Regulated Factor (PAUF) Transforms Human Monocytes into Alternative M2 Macrophages with Immunosuppressive Action. Last author DOI 10.3390/ijms252111545↗
  2. PAUF as a Target for Treatment of High PAUF-Expressing Ovarian Cancer Last author DOI 10.3389/fphar.2022.890614↗
  3. PAUF Induces Migration of Human Pancreatic Cancer Cells Exclusively via the TLR4/MyD88/NF-κB Signaling Pathway. Last author DOI 10.3390/ijms231911414↗
  4. Pancreatic cancer induces muscle wasting by promoting the release of pancreatic adenocarcinoma upregulated factor. Co-author DOI 10.1038/s12276-021-00582-2↗
  5. Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer. Co-author DOI 10.1038/s41598-018-30582-8↗
  6. DCPP1 is the mouse ortholog of human PAUF that possesses functional analogy in pancreatic cancer. Last author DOI 10.1016/j.bbrc.2017.10.015↗
  7. Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the accumulation and functional activity of myeloid-derived suppressor cells (MDSCs) in pancreati… Co-author DOI 10.18632/oncotarget.10123↗
  8. Pancreatic adenocarcinoma upregulated factor (PAUF) confers resistance to pancreatic cancer cells against oncolytic parvovirus H-1 infection through IFNA recep… Co-author DOI 10.1016/j.bbrc.2015.02.107↗
  9. Pancreatic adenocarcinoma upregulated factor serves as adjuvant by activating dendritic cells through stimulation of TLR4. Co-author DOI 10.18632/oncotarget.4859↗
  10. Oncotropic H-1 parvovirus infection degrades HIF-1α protein in human pancreatic cancer cells independently of VHL and RACK1. Co-author DOI 10.3892/ijo.2015.2922↗
  11. Efficient targeting and tumor retardation effect of pancreatic adenocarcinoma up-regulated factor (PAUF)-specific RNA replacement in pancreatic cancer mouse mo… Co-author DOI 10.1016/j.canlet.2013.10.028↗
  12. Pancreatic adenocarcinoma upregulated factor, a novel endothelial activator, promotes angiogenesis and vascular permeability. Last author DOI 10.1038/onc.2012.366↗
  13. Collagen triple helix repeat containing-1 promotes pancreatic cancer progression by regulating migration and adhesion of tumor cells. Last author DOI 10.1093/carcin/bgs378↗
  14. SIRT1 inhibits proliferation of pancreatic cancer cells expressing pancreatic adenocarcinoma up-regulated factor (PAUF), a novel oncogene, by suppression of β-… First author DOI 10.1016/j.bbrc.2012.05.107↗
  15. An RNA aptamer that specifically binds pancreatic adenocarcinoma up-regulated factor inhibits migration and growth of pancreatic cancer cells. Co-author DOI 10.1016/j.canlet.2011.08.027↗
  16. Pancreatic adenocarcinoma upregulated factor promotes metastasis by regulating TLR/CXCR4 activation. Co-author DOI 10.1038/onc.2010.401↗
  17. Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the expression of β-catenin, leading to a rapid proliferation of pancreatic cells. First author DOI 10.3858/emm.2011.43.2.010↗
  18. PAUF promotes adhesiveness of pancreatic cancer cells by modulating focal adhesion kinase. Last author DOI 10.3858/emm.2011.43.5.030↗

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tae Heung Kang · 5 shared papers, 2015–2024 · strength 0.58
  2. Yeon‐Jeong Kim · 4 shared papers, 2016–2022 · strength 0.40
  3. Fen Jiang · 2 shared papers, 2022 · strength 0.34
  4. Yeon Jeong Kim · 1 shared paper, 2024 · strength 0.24
  5. So Eun Youn · 1 shared paper, 2022 · strength 0.17
  6. Seung‐Mo Hong · 1 shared paper, 2022 · strength 0.16
  7. Seokho Kim · 3 shared papers, 2013–2018 · strength 0.16
  8. Il-Rae Cho · 4 shared papers, 2011–2015 · strength 0.15
  9. Young-Hwa Chung · 4 shared papers, 2011–2015 · strength 0.15
  10. Song Cheol Kim · 2 shared papers, 2016–2021 · strength 0.15
  11. Hayne Song · 2 shared papers, 2015–2017 · strength 0.13
  12. Jinhoi Song · 2 shared papers, 2016–2017 · strength 0.13
  13. Wonbeak Yoo · 1 shared paper, 2021 · strength 0.11
  14. Seok‐Ho Kim · 1 shared paper, 2021 · strength 0.11
  15. Eunsung Jun · 1 shared paper, 2021 · strength 0.11
  16. Dana Jung · 1 shared paper, 2021 · strength 0.11
  17. Sirichat Kaowinn · 2 shared papers, 2015 · strength 0.10
  18. Jae‐Hoon Kim · 1 shared paper, 2018 · strength 0.08
  19. Stephen M. Hewitt · 1 shared paper, 2018 · strength 0.08
  20. Chel Hun Choi · 1 shared paper, 2018 · strength 0.08
  21. Eun Hye Park · 2 shared papers, 2011–2013 · strength 0.07
  22. In-Hoo Kim · 2 shared papers, 2011–2014 · strength 0.06
  23. Ratakorn Srisuttee · 2 shared papers, 2011–2012 · strength 0.06
  24. Jae Min Lee · 1 shared paper, 2016 · strength 0.05
  25. Suhwan Chang · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.